Pharmaceutical Safety Assessment Market Growth Is Reshaping Competitive Advantage Across The Industry
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Pharmaceutical Safety Assessment Market Forecast: What Market Value Is Expected By 2030?
The pharmaceutical safety assessment market has experienced robust expansion in recent times. Projected to rise from $11.32 billion in 2025 to $12.24 billion in 2026, this growth corresponds to a compound annual growth rate (CAGR) of 8.2%. Historically, this upward trend has been driven by the broadening of pharmaceutical research and development pipelines, heightened regulatory demands regarding drug safety, an uptick in preclinical and clinical testing activities, greater implementation of in-vitro safety evaluation techniques, and an increased reliance on contract research organizations for safety studies.
The pharmaceutical safety assessment market is projected to experience substantial growth in the coming years. By 2030, its value is anticipated to reach $16.97 billion, reflecting a compound annual growth rate (CAGR) of 8.5%. This expansion in the forecast period is driven by factors such as a growing dependence on computational safety evaluation, the broadening of personalized medicine development, heightened demand for expedited regulatory approvals, greater incorporation of artificial intelligence into drug safety operations, and increased requirements for post-market surveillance. Key trends shaping this period include more widespread application of AI-driven toxicity prediction tools, a growing reliance on in-silico safety assessment methods, deeper integration of real-time pharmacovigilance systems, broader adoption of automated platforms for preclinical testing, and a stronger emphasis on safety analytics that meet regulatory standards.
Download A Free Sample Report For Comprehensive Market Insights:
Pharmaceutical Safety Assessment Market Opportunity Drivers: What Is Creating New Revenue Potential?
The anticipated growth of the pharmaceutical safety assessment market is being driven forward by the expanding scope of clinical trials. These trials are defined as human research studies that assess the safety, efficacy, and potential side effects of novel medical treatments, drugs, or interventions. An upsurge in clinical trials is occurring because of an increased demand for innovative and effective therapies, as researchers and healthcare professionals strive to develop improved methods for preventing, managing, or curing diseases. Through systematically examining a drug’s impact on humans in tightly controlled settings, monitoring for adverse events, establishing safe dosage levels, and generating critical data for regulatory bodies to confirm that medications are both safe and effective for public consumption, clinical trials play a key role in supporting pharmaceutical safety assessment. For example, the National Library of Medicine (NLM), a US-based biomedical library, reported that by September 26, 2025, 554,798 studies were registered on ClinicalTrials.gov. Consequently, the increasing number of clinical trials is fueling growth in the pharmaceutical safety assessment market.
Pharmaceutical Safety Assessment Market Segment Landscape And Growth Potential
The pharmaceutical safety assessment market covered in this report is segmented –
1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment
2) By Drug Type: Biological Drugs, Chemical Drugs
3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)
4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)
Subsegments:
1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening
2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies
3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies
Pharmaceutical Safety Assessment Market Innovation Trends Driving Future Development
Major players in the pharmaceutical safety assessment sector are placing growing emphasis on the creation of AI-driven decision support systems aimed at boosting both the precision and effectiveness of toxicity prediction and safety profiling. Such a system constitutes software that leverages artificial intelligence to interpret data, thereby generating insights conducive to quicker and more reliable decision-making. A case in point occurred in April 2024, when Charles River Laboratories—a life sciences firm based in the United States—teamed up with Deciphex, an Irish company that enhances diagnostic speed and accuracy through AI-based quality control, to unveil the Patholytix Foresight platform. This AI-enabled decision support tool seeks to revolutionize toxicologic pathology within pharmaceutical safety evaluations. By rapidly processing intricate preclinical pathology data through artificial intelligence, the platform can flag potential safety issues earlier and minimize the subjectivity embedded in outcomes. Among its distinct attributes are an AI algorithm capable of detecting alterations in tissues, a cloud-hosted infrastructure enabling worldwide cooperation, and an expandable architecture that cuts down on the time needed for slide review while simultaneously elevating data precision and operational efficiency.
Pharmaceutical Safety Assessment Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.
Access The Complete Pharmaceutical Safety Assessment Market Report:
Pharmaceutical Safety Assessment Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical safety assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
